相似文献
1
Development and evaluation of berberine-loaded bigel for the treatment of hyperpigmentation on B16F10 melanoma cell line.载黄连素双凝胶的制备及其对 B16F10 黑素瘤细胞系色素沉着的治疗作用评价。
Nanomedicine (Lond). 2024;19(18-20):1659-1673. doi: 10.1080/17435889.2024.2370759. Epub 2024 Jul 26.
2
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病：网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Topical versus systemic antibiotics for chronic suppurative otitis media.用于慢性化脓性中耳炎的局部用抗生素与全身用抗生素对比
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013053. doi: 10.1002/14651858.CD013053.pub3.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗：一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中，如果患者出现以下症状和体征，可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Topical tacrolimus for atopic dermatitis.外用他克莫司治疗特应性皮炎。
Cochrane Database Syst Rev. 2015 Jul 1;2015(7):CD009864. doi: 10.1002/14651858.CD009864.pub2.
本文引用的文献
1
Disorders of Facial Hyperpigmentation.面部色素沉着障碍。
Dermatol Clin. 2023 Jul;41(3):393-405. doi: 10.1016/j.det.2023.02.005. Epub 2023 Apr 14.
2
Targeting tyrosinase in hyperpigmentation: Current status, limitations and future promises.靶向黑色素生成中的酪氨酸酶：现状、局限性和未来前景。
Biochem Pharmacol. 2023 Jun;212:115574. doi: 10.1016/j.bcp.2023.115574. Epub 2023 Apr 29.
3
Formulation Development and In Vitro/In Vivo Characterization of Methotrexate-Loaded Nanoemulsion Gel Formulations for Enhanced Topical Delivery.用于增强局部给药的载甲氨蝶呤纳米乳凝胶制剂的处方开发及体外/体内表征
Gels. 2022 Dec 22;9(1):3. doi: 10.3390/gels9010003.
4
Formulation and development of novel lipid-based combinatorial advanced nanoformulation for effective treatment of non-melanoma skin cancer.新型基于脂质的组合式先进纳米制剂的配方和开发，用于有效治疗非黑色素瘤皮肤癌。
Int J Pharm. 2023 Feb 5;632:122580. doi: 10.1016/j.ijpharm.2022.122580. Epub 2023 Jan 3.
5
Design-of-Experiments (DoE)-Assisted Fabrication of Quercetin-Loaded Nanoemulgel and Its Evaluation against Human Skin Cancer Cell Lines.实验设计（DoE）辅助制备载槲皮素纳米乳凝胶及其对人皮肤癌细胞系的评价
Pharmaceutics. 2022 Nov 19;14(11):2517. doi: 10.3390/pharmaceutics14112517.
6
Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review.从药用植物中提取的黄连素的抗癌作用及其机制：最新综述。
Molecules. 2022 Jul 15;27(14):4523. doi: 10.3390/molecules27144523.
7
Chitosan hydrogel for topical delivery of ebastine loaded solid lipid nanoparticles for alleviation of allergic contact dermatitis.用于局部递送载有依巴斯汀的固体脂质纳米粒以缓解过敏性接触性皮炎的壳聚糖水凝胶。
RSC Adv. 2021 Nov 22;11(59):37413-37425. doi: 10.1039/d1ra06283b. eCollection 2021 Nov 17.
8
Disorders of hyperpigmentation. Part I. Pathogenesis and clinical features of common pigmentary disorders.色素沉着障碍。第一部分。常见色素障碍的发病机制和临床特征。
J Am Acad Dermatol. 2023 Feb;88(2):271-288. doi: 10.1016/j.jaad.2022.01.051. Epub 2022 Feb 11.
9
A review of the berberine natural polysaccharide nanostructures as potential anticancer and antibacterial agents.天然小檗碱多糖纳米结构作为潜在的抗癌和抗菌剂的研究进展。
Biomed Pharmacother. 2022 Feb;146:112531. doi: 10.1016/j.biopha.2021.112531. Epub 2021 Dec 11.
10
Management of hyperpigmentation: Current treatments and emerging therapies.色素沉着过度的管理：现有治疗方法和新兴疗法。
Pigment Cell Melanoma Res. 2021 Nov;34(6):1000-1014. doi: 10.1111/pcmr.12986. Epub 2021 Jun 3.
Zotero 插件